Nona Biosciences Announces Licensing Agreement with the University of Alabama at Birmingham to Support B Cell Development Research
Nona Biosciences, a global biotechnology company providing a total solution from "Idea to IND" (I to I™), today announced a ...
CAR-TCR Summit Coverage – Track Latest Insights on Novel CAR-T Cell Therapies for B-Cell Malignancies | DelveInsight
A case study on how DelveInsight supported a client with a focused CAR-TCR Summit coverage plan to gain exclusive insights into CAR-T therapies for B-cell malignancies.New York, USA, Feb. 21, 2025 (GL ...
Oncology Nurse Advisor3d
Ibrutinib, Acalabrutinib Have Distinct Metabolic Effects on CLL Cells
Cells treated with ibrutinib and acalabrutinib each had a unique set of 13 m/z signals, which opens up the possibility of studying these metabolites as biomarkers of therapeutic response.
PMLiVE8d
Pfizer granted FDA approval for Adcetris combination in large B-cell lymphoma
Pfizer’s Takeda-partnered blood cancer drug Adcetris (brentuximab vedotin) has been approved by the US Food and Drug ...